Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.850
+0.050 (2.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.850
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:01 AM EDT
Serina Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -19.18 | -11.14 | 5.27 | -2.68 | -1.26 |
| Depreciation & Amortization | 0.07 | 0.19 | 0.09 | 0.06 | 0.03 |
| Other Amortization | 0.06 | 0.35 | - | - | - |
| Loss (Gain) From Sale of Assets | 0.26 | - | - | 0 | -0.03 |
| Loss (Gain) From Sale of Investments | - | - | - | 0.01 | 0.01 |
| Stock-Based Compensation | 3.82 | 2.6 | 0.03 | 0.01 | 0.08 |
| Other Operating Activities | -4.45 | -5.81 | -7.94 | 0.54 | -0.33 |
| Change in Accounts Receivable | - | - | - | 0 | 1.27 |
| Change in Accounts Payable | 1.2 | -1.66 | 0.39 | -0 | -0.37 |
| Change in Unearned Revenue | - | 0.07 | - | 0.15 | -1.61 |
| Change in Other Net Operating Assets | 0.27 | -1.72 | -0.31 | -0.16 | -0.05 |
| Operating Cash Flow | -17.96 | -17.14 | -2.48 | -2.08 | -2.25 |
| Capital Expenditures | -0.06 | -0.02 | -0.5 | -0.01 | -0.08 |
| Investment in Securities | - | - | - | 0.99 | 0.93 |
| Investing Cash Flow | -0.06 | -0.02 | -0.5 | 0.98 | 0.82 |
| Long-Term Debt Issued | 4.91 | 3.04 | 10.1 | 5 | - |
| Long-Term Debt Repaid | - | -0.17 | -0.05 | -3.69 | -0.01 |
| Net Debt Issued (Repaid) | 4.91 | 2.88 | 10.05 | 1.31 | -0.01 |
| Issuance of Common Stock | 7.56 | 10 | 0.02 | 0 | 1 |
| Other Financing Activities | - | 0.34 | - | - | - |
| Financing Cash Flow | 17.41 | 13.21 | 10.07 | 1.31 | 1.08 |
| Foreign Exchange Rate Adjustments | -0.01 | - | - | - | - |
| Net Cash Flow | -0.62 | -3.95 | 7.09 | 0.22 | -0.35 |
| Free Cash Flow | -18.01 | -17.16 | -2.98 | -2.09 | -2.34 |
| Free Cash Flow Margin | -13856.92% | -30641.07% | -94.51% | -352.55% | -67.41% |
| Free Cash Flow Per Share | -1.77 | -2.33 | -0.41 | -0.97 | -1.09 |
| Cash Interest Paid | 0.02 | - | - | 0.02 | 0 |
| Levered Free Cash Flow | -11.29 | -7.75 | -0.82 | -1.22 | - |
| Unlevered Free Cash Flow | -11.21 | -7.77 | -0.48 | -1.21 | - |
| Change in Working Capital | 1.47 | -3.32 | 0.08 | -0.01 | -0.75 |
Source: S&P Capital IQ. Standard template.
Financial Sources.